Immune-complex-mediated injury is thought to play a role in diseases such as rheumatoid arthritis, systemic lupus erythematosus, serum sickness, various infectious diseases, and malignancies. With increased appreciation of the biological and pathological significance of circulating immune complexes has come efforts to develop appropriate techniques for identifying and measuring them.
Common approaches exploit such phenomena as the attachment of complement components to antigen-antibody complexes, the presence of specialized receptors for immune complexes at the surface of cells, and the ability of rheumatoid factor to bind with immune complexes. This variety of assay systems for immune complexes has yielded abstruse results in numerous human pathological conditions. Unfortunately, these results seldom correlate with one another in a given disease. Thus, use of a panel of immune complex assays has been recommended. Indirect consequences of immune complex disease may still be appraised and evaluated with some confidence in clinical medicine: measurements of C3 and C4, cryoglobulins, serum viscosity, and turbidity of serum samples. Measurement of immune complexes may be useful in diagnosis, prognosis, and therapeutic monitoring, but it is the characterization of immune complexes that holds the greatest potential for better understanding of disease mechanisms.
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The origin of the concept of immune complex diseases dates back 120 years to a report by Maurice Raynaud in which he detailed the clinical manifestations of patients with cyanosis, pallor, purpura, or gangrene that were aggravated by the patients' exposure to cold (1) . These conditions are known collectively as Raynaud's syndrome or, more encompassingly, as cryopathies (2) (3) (4) . They are diverse in etiology, require multifaceted diagnostic considerations, and demand individualized clinical management. The immune complexes underlying many of these disorders are protean in nature and are unpredictable with respect to their clinical implications. Cryoglobulins are the most striking physicochemical expression of circulating immune complexes. In the 1950s, the pioneering work of Germuth (5) and Dixon et a!. (6) elucidated the principal pathogenic mechanisms by which immune complexes lead to experimental serum sickness.
After certain antigens such as bovine serum albumin are injected into rabbits, antibodies appear in the circulation that may consume complement and result 'Department of Pathology, Baylor University Medical Center, and Subsequently, in both experimental animals and patients, immune complex deposition was shown to lead to glomerulonephritis.
The glomerular capillaries are the prime target for deposition of circulating immune complexes (CIC).3 These deposits are typically characterized by immunofluorescence as "lumpy-bumpy" granular deposits of IgG (7, 8) . The mechanism currently is considered to be responsible for 70 to 80% of cases of human glomerulonephritis (4) . CIC are removed from the circulation mainly by deposition in the specialized vasculature of specific organs, including the kidneys, arteries, skin, lungs, joints, and choroid plexus. The mesangium of the glomerulus is noteworthy for its ability to clear macromolecular substances from the blood. It appears to be the kidney's primary defense against CIC (10).
Nature and Function of Immune Complexes
Immune complexes are formed in the circulation or tissues (9, (17) (18) (19) , infectious diseases (7, 9, (18) (19) (20) (21) , malignancies (7, (17) (18) (19) 22) , and numerous other conditions (7, (17) (18) (19) (23) (24) (25) (26) 
Pathophyslology of Immune Complexes
Factors determining the localization of CIC in vessel walls within a particular organ include the quantity, size, and lattice-structure of CIC (19, 31 Arthus's phenomenon can be produced by local injection of an antigen into an animal, with subsequent reaction in situ to its corresponding antibodies. Certain kidney diseases and other disorders with local formation of immune complexes may be considered to represent human analogs of the Arthus phenomenon (e.g., Goodpasture's syndrome associated with deposition of antibodies directed to the basement membrane of kidneys and lungs).
Clinical Correlation of Circulating Immune Complexes
In general, the correlation between results obtained by the For instance, CIC concentrations and the disease activity are closely related in certain patients with systemic lupus erythematosus, the archetype of human immune complexrelated diseases. CIC may disappear when there is remission in this disorder (19, 31, 38) . Thus, monitoring CIC concentrations may allow the gauging of therapeutic effectiveness in systemic lupus erythematosus.
Similarly, in other autoimmune disorders the efficacy of anti-inflammatory and plasmapheresis intervention may be monitored by serial CIC determinations (19, 31, 38) .
In bacterial endocarditis, an excellent correlation has been established between CIC values, duration of the disease, extravalvular manifestations, and the therapeutic response to antibiotics (38,40) . If high CIC values persist, they may reflect a failure of antibiotic therapy, and surgical intervention may become necessary (19, 31, 38) .
In certain malignancies, data on CIC concentrations may have prognostic significance, and may be used to judge the efficacy with which surgery or radiological treatment has decreased the tumor load. In certain others, the recurrence of a neoplasm may be heralded by increasing CIC values (19, 31, 38) .
Other examples of the usefulness of CIC assays are the Agnello syndrome, a disorder related to systemic lupus erythematosus and characterized by hypocomplementemic cutaneous vasculitis in which a Clq reactant appears to be a marker for the disease (10, 41) , and the Lymes arthritis with neurological, cardiac, and synovial involvement, characterized by persistently positive Clq assays (41). These developments, and applications of the rapidly accumulating information about dC, should prompt the clinical laboratory to provide some basic, albeit indirect, CIC assays, either itself or via reference laboratories.
Assays of Circulating Immune Complexes
The plethora of experimental and clinical data incriminating immune complexes in the etiology and pathogenesis of more than 100 diseases (41) was in contrast to the paucity of reliable diagnostic assays for the detection, quantitation, and characterization of dC. But now there are more than 40 such assays advocated for use in the clinical laboratory, many of them pioneered by Theofilopoulos and Dixon (9, 19, 22, 31, 42) . Table 2 task of routinely identifying the putative antigens in the immune complexes. In exceptional cases, however, antigens can be identified by some tests in clinically suspected situations, such as the hepatitis A or B viral antigens (7, 9, 18, 19, 21, 31) .
Many of these tests are impeded either by low sensitivity or specificity, or a host of interfering factors, or lack of reference preparations,5 or economic aspects, or some combination of these (46) . For instance, rheumatoid factor-dependent tests are interfered with by intrinsic rheumatoid factor; Clq by free DNA, bacterial endotoxin, and other serum proteins; and the Raji cell test by antilymphocyte antibodies in patients with certain autoimmune disorders (45) , as well as by its relatively high cost.
The principles of some of these assays for CIC is summarized in the following paragraphs.
Ultracentrifugation
This rather insensitive approach is applicable for the detection of low, intermediate (7-19 S) , and high (>19 S) CIC when their proportion exceeds 5% of total serum proteins (Table 3-dId types I, II, III, which are reflected either as cryogbobulins, increased viscosity, or simply by turbidity) (47).
Precipitation with Polyethylene Glycol (PEG) (38)
High concentrations (e.g., 200 g/L) of this water-soluble polysaccharide polymer precipitate most serum proteins, but low concentrations (e.g., 20 to 40 gIL) preferentially precipitate large CIC without, for all practical purposes, affecting any other immunoglobulins or other serum proteins. Thisselective effect may be due to steric exclusion of immune complexes from the domain of the polymer (48).
Complement Consumption Tests (49)
In these screening tests, incubation of complement-binding dId with standard amounts of complement allows quantita- Rheumatoid Factor (RF) Tests .1
IgA (a)
'1gM (,.) serum turbidity due to CIC is aggravated by refrigeration and usually diminished by warming to 37 #{176}C. The mere detection of cryoglobulinemia, increased serum viscosity, or CIC-related serum turbidity should not be a diagnostic endpoint in itself. Rather, it should prompt immunological characterization and, whenever feasible, the appropriate clinical correlation and followup. To facilitate this approach, one needs an all-encompassing immunodiagnostic and clinical classification of cryoglobulins and, by extension, of increased serum viscosity and CIC-caused turbidity. The classification of Brouet et al. (26) satisfies these criteria. It is based on the analysis of the immunochemical nature of cryoglobulins from 86 patients and their correlation with the corresponding clinical manifestations (Table 3 ). Other studies (2, 69) have corroborated this approach. Briefly, Category I cryoglobulins ( Figure 9 ) consist of monoclonal immunoglobulins, mainly 1gM, usually without recognizable immunoglobulin antigen targets, usually IgG. Clinically, monoclonal B-cell disorders of the symptomatic variety (e.g., multiple myeloma, macroglobulinemia Waldenstr#{246}m, and chronic lymphocytic leukemia) or the asymptomatic benign forms are associated with this category of cryoglobulins.
Category II and III cryoglobulins are mixed cryoglobulins in that both the antibody and antigen components forming the CIC are required for cryoglobulin production; neither component by itself will result in cryoglobulin formation. Category II CIC ( Figure 10 ) are due to monoclonal immunoglobulins and polyclonal immunoglobulins or other proteins.
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Ig ( ) Most frequently encountered are monoclonal 1gM antibodies to autologous polyclonal IgG (i.e., RF), but nonimmunoglobulin autologous antigens (e.g., lipoproteins and albumin) (Figure lOc) , are also seen, as well as allogeneic or heterologous antigens (e.g., porcine, caprine, and bovine meat-and milkprotein antigens), especially in patients with selective IgA deficiency (15) . Category III CIC (Figure 11) (7, 9, 17, 18, 67) .
In about 50% of the diseases in this category, the underlying cause remains elusive (idiopathic cryoglobulinemia).
Type III CIC diseases are often complicated by vasculitis and glomerulonephritis
(62).
The relative incidences of CIC of categories I, II, and III are about 25, 25, and 50%, respectively. During recent years, it has become evident that certain unusual y-globulin configurations on serum protein electrophoresis correlate with the presence of dC. These consist variously of plateau formation (Figure 11 ), banding patterns, block formation, or unusual forms of asymmetries (Figure lOa,b,c) . These patterns are found on both cellulose acetate and highresolution agarose electropherograms, but not necessarily by both methods on the same serum. 
Immunoelectrophoresis (IEP) (82,83).
IEP without subsequent staining (i.e., wet analysis) may provide useful, albeit nonspecific, evidence of CIC. An example is the "milky" trailing from the point of application towards the cathode, a phenomenon that can also be produced by M-proteins (Figures 9, lOa) . Parallel, double IgG precipitin lines (Figure 11 ) or simply by fourfold dilution of the serum with 0.14 mol/L saline, usually allows their characterization as true monoclonal 1gM, IgA, or IgG. Cryoglobulins of high relative molecular mass may not enter the agarose gel, yielding misleading negative results. Depolymerization with 2-mercaptoethanol or temperature equilibration of reagents to at least room temperature, or both, may be required under these circumstances. Circumstantial evidence for CIC may be provided by the appearance of double or triple rings on radial immunodiffusion plates when serum is assayed for immunoglobulins.
However, M-proteins may simulate such patterns (84).
Conclusions and Projections
The increasing realization of the clinical significance of dId in health and disease is confounded by the methodological limitations, owing to the extreme complexity, heterogeneity, and diversity of CIC. Thus a series of tests must be available if the clinical laboratory is to provide a satisfactory service during this time of transition. The numerous assays becoming available for the detection and quantitation of dId currently are restricted to larger hospitals and special reference laboratories. The ancillary tests There is something fascinating about science. One gets such wholesale returns of conjecture out of such trifling investment of facts.
Instead, he might wryly have surmised the future of dId assays to be visual, direct, and simple with the aid of dedicated electron-microscopic equipment.
